Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPIART · Entity 2707 | Director | May 07, 2026 | May 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTEGRA LIFESCIENCES HOLDINGS CORP
Report date May 07, 2026 · Filed May 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 88,254 |
Reported balance
After 2026-05-09 transaction · row 1
1 source rowRow 1 · 2026-05-09 · Tax withholding · Disposed 882 · Balance 88,254 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 17,700 |
Reported balance
After 2026-05-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-07 · Grant · Acquired 17,700 · Balance 17,700 F1: Grant of restricted stock units (RSUs) pursuant to the Integra LifeSciences Holdings Corporation (IART) Fifth Amended and Restated 2003 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of IART common stock. F2: RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units (RSUs) pursuant to the Integra LifeSciences Holdings Corporation (IART) Fifth Amended and Restated 2003 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of IART common stock.
F2: RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SeaSpine Holdings Corp
Report date January 05, 2023 · Filed January 10, 2023
Section 16 reporting ended · disclosed 2023-01-10. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 1
1 source rowRow 1 · 2023-01-05 · Disposition to issuer · Disposed 88,592 · Balance 0 F1: Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 36,880 Orthofix MedicalInc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.68 · Expires 2025-08-01 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-01-05 · Disposition to issuer · Disposed 58,559 · Balance 0 F3: This option was assumed by Orthofix in the merger and replaced with an option to purchase 24,378 shares of Orthofix at a price of $37.67 per share. F2: The option vests as to 25% of the underlying shares on November 1, 2015 and the remaining 75% in three equal quarterly installments thereafter. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.18 · Expires 2026-01-01 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-01-05 · Disposition to issuer · Disposed 3,858 · Balance 0 F5: This option was assumed by Orthofix in the merger and replaced with an option to purchase 1,606 shares of Orthofix at a price of $41.27 per share. F4: The option vests as to 50% of the underlying shares on February 1, 2016 and as to 25% of the underlying shares on each of May 1, 2016 and August 1, 2016. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.99 · Expires 2026-06-07 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-01-05 · Disposition to issuer · Disposed 13,920 · Balance 0 F7: This option was assumed by Orthofix in the merger and replaced with an option to purchase 5,794 shares of Orthofix at a price of $24.00 per share. F6: The options vests in equal installments on each of September 7, 2016, December 7, 2016, March 7, 2016 and June 7, 2016. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 36,880 Orthofix MedicalInc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger.
F2: The option vests as to 25% of the underlying shares on November 1, 2015 and the remaining 75% in three equal quarterly installments thereafter.
F3: This option was assumed by Orthofix in the merger and replaced with an option to purchase 24,378 shares of Orthofix at a price of $37.67 per share.
F4: The option vests as to 50% of the underlying shares on February 1, 2016 and as to 25% of the underlying shares on each of May 1, 2016 and August 1, 2016.
F5: This option was assumed by Orthofix in the merger and replaced with an option to purchase 1,606 shares of Orthofix at a price of $41.27 per share.
F6: The options vests in equal installments on each of September 7, 2016, December 7, 2016, March 7, 2016 and June 7, 2016.
F7: This option was assumed by Orthofix in the merger and replaced with an option to purchase 5,794 shares of Orthofix at a price of $24.00 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 16, 2020 Filed Feb 18, 2020 22:02 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 43 | $58.93 | $2,533.99 |
DisclosureSEC source: 0001209191-20-010247 · doc4.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,779 Read SEC document |
| February 16, 2020 Filed Feb 18, 2020 22:02 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 9 | $58.93 | $530.37 |
DisclosureSEC source: 0001209191-20-010247 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,822 Read SEC document |
| November 29, 2019 Filed Dec 3, 2019 00:50 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 54 | $13.23 | $714.42 |
DisclosureSEC source: 0001637761-19-000106 · wf-form4_157533419651411.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,283 F1 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on November 29, 2019. No shares were sold in connection with this transaction. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 21:52 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 43 | $58.43 | $2,512.49 |
DisclosureSEC source: 0001209191-19-057215 · doc4.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,831 Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 21:52 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 9 | $58.43 | $525.87 |
DisclosureSEC source: 0001209191-19-057215 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,874 Read SEC document |
| August 29, 2019 Filed Sep 3, 2019 20:36 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 54 | $11.14 | $601.56 |
DisclosureSEC source: 0001637761-19-000098 · wf-form4_156754294935808.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,337 F1 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on August 29, 2019. No shares were sold in connection with this transaction. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 21:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 43 | $61.02 | $2,623.86 |
DisclosureSEC source: 0001209191-19-046830 · doc4.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,883 Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 21:17 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 9 | $61.02 | $549.18 |
DisclosureSEC source: 0001209191-19-046830 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,926 Read SEC document |
| May 30, 2019 Filed May 31, 2019 20:14 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 449 | $14.01 | $6,290.49 |
DisclosureSEC source: 0001637761-19-000079 · wf-form4_155933364923345.xml · nonDerivative · entry 3 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,391 F3 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on May 30, 2019. No shares were sold in connection with this transaction. F4 · balance_after: On July 1, 2015, Integra LifeSciences Holdings Corporation ("Integra") distributed 100% of the shares of common stock of SeaSpine that it owned to Integra stockholders of record as of the close of business on June 19, 2015. The distribution was made to the stockholders of Integra on a pro rata basis by means of a share dividend. Integra distributed to its stockholders one share of SeaSpine common stock for every three shares of Integra common stock held by stockholders of Integra as of the close of business on June 19, 2015. The distribution of SeaSpine shares was exempt from Section 16 of the Exchange Act by Rule 16a-9. Includes 3,727 shares of SeaSpine issued to the Reporting Person pursuant to the distribution in respect of shares of Integra held by him prior to the distribution. Read SEC document |
| May 29, 2019 Filed May 31, 2019 20:14 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantCommon Stock | 4,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-19-000079 · wf-form4_155933364923345.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,840 F2 · shares: The restricted stock award vests as to 25% of the shares subject to the award on the last day of each three-month period of the Reporting Person's continuous service on SeaSpine's board of directors following May 29, 2019. Read SEC document |
| May 29, 2019 Filed May 31, 2019 20:14 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantCommon Stock | 7,262 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-19-000079 · wf-form4_155933364923345.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,120 F1 · shares: The restricted stock award vests in full on May 29, 2020, subject to the Reporting Person not experiencing a termination of service prior to such date. In addition, if the Reporting Person stands for reelection to the board of directors of SeaSpine Holdings Corporation ("SeaSpine") at an annual meeting of stockholders but is not reelected to the board at such annual meeting, the award will vest in full on the date of such annual meeting. Read SEC document |
| May 17, 2019 Filed May 20, 2019 20:24 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 34 | $49.43 | $1,680.62 |
DisclosureSEC source: 0001209191-19-031383 · doc4.xml · nonDerivative · entry 4 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,935 Read SEC document |
| May 17, 2019 Filed May 20, 2019 20:24 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 7 | $49.43 | $346.01 |
DisclosureSEC source: 0001209191-19-031383 · doc4.xml · nonDerivative · entry 3 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,969 Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:24 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 747 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031383 · doc4.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,976 Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:24 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 3,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031383 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,229 Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 21:54 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 50 | $15.34 | $767.00 |
DisclosureSEC source: 0001637761-19-000045 · wf-form4_155147724848759.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,858 F1 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on February 28, 2019. No shares were sold in connection with this transaction. Read SEC document |
| February 17, 2019 Filed Feb 20, 2019 23:15 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 34 | $51.06 | $1,736.04 |
DisclosureSEC source: 0001209191-19-011762 · doc4.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,444 Read SEC document |
| February 17, 2019 Filed Feb 20, 2019 23:15 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon stock | 7 | $51.06 | $357.42 |
DisclosureSEC source: 0001209191-19-011762 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,478 Read SEC document |
| November 30, 2018 Filed Dec 3, 2018 23:27 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 50 | $19.66 | $983.00 |
DisclosureSEC source: 0001637761-18-000148 · wf-form4_154387965214727.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,908 F1 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on November 30, 2018. No shares were sold in connection with this transaction. Read SEC document |
| November 17, 2018 Filed Nov 27, 2018 22:54 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 34 | $54.28 | $1,845.52 |
DisclosureSEC source: 0001209191-18-060020 · doc4.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,485 Read SEC document |
| November 17, 2018 Filed Nov 27, 2018 22:54 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 7 | $54.28 | $379.96 |
DisclosureSEC source: 0001209191-18-060020 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,519 Read SEC document |
| August 30, 2018 Filed Aug 31, 2018 21:46 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 50 | $14.87 | $743.50 |
DisclosureSEC source: 0001637761-18-000131 · wf-form4_153575196442642.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,958 F1 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on August 30, 2018. No shares were sold in connection with this transaction. Read SEC document |
| August 17, 2018 Filed Aug 21, 2018 21:24 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 34 | $58.97 | $2,004.98 |
DisclosureSEC source: 0001209191-18-047783 · doc4.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,526 Read SEC document |
| August 17, 2018 Filed Aug 21, 2018 21:24 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 7 | $58.97 | $412.79 |
DisclosureSEC source: 0001209191-18-047783 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,560 Read SEC document |
| June 14, 2018 Filed Jun 15, 2018 00:00 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 171 | $14.03 | $2,399.13 |
DisclosureSEC source: 0001637761-18-000102 · wf-form4_152902081767139.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,008 F1 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on June 14, 2018. No shares were sold in connection with this transaction. Read SEC document |
| May 30, 2018 Filed May 31, 2018 20:55 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantCommon Stock | 4,429 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-18-000098 · wf-form4_152780005909518.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,179 F2 · shares: The restricted stock award vests as to 25% of the shares subject to the award on the last day of each three-month period of the Reporting Person's continuous service on SeaSpine's board of directors following May 30, 2018. F3 · balance_after: On July 1, 2015, Integra LifeSciences Holdings Corporation ("Integra") distributed 100% of the shares of common stock of SeaSpine that it owned to Integra stockholders of record as of the close of business on June 19, 2015. The distribution was made to the stockholders of Integra on a pro rata basis by means of a share dividend. Integra distributed to its stockholders one share of SeaSpine common stock for every three shares of Integra common stock held by stockholders of Integra as of the close of business on June 19, 2015. The distribution of SeaSpine shares was exempt from Section 16 of the Exchange Act by Rule 16a-9. Includes 3,727 shares of SeaSpine issued to the Reporting Person pursuant to the distribution in respect of shares of Integra held by him prior to the distribution. Read SEC document |
| May 30, 2018 Filed May 31, 2018 20:55 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantCommon Stock | 8,857 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-18-000098 · wf-form4_152780005909518.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,750 F1 · shares: The restricted stock award vests in full on May 30, 2019, subject to the Reporting Person not experiencing a termination of service prior to such date. In addition, if the Reporting Person stands for reelection to the board of directors of SeaSpine Holdings Corporation ("SeaSpine") at an annual meeting of stockholders but is not reelected to the board at such annual meeting, the award will vest in full on the date of such annual meeting. Read SEC document |
| May 23, 2018 Filed May 24, 2018 20:24 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 9 | $63.99 | $575.91 |
DisclosureSEC source: 0001209191-18-032973 · doc4.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,567 Read SEC document |
| May 23, 2018 Filed May 24, 2018 20:24 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 40 | $63.99 | $2,559.60 |
DisclosureSEC source: 0001209191-18-032973 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,576 Read SEC document |
| May 18, 2018 Filed May 21, 2018 23:06 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionStock Option (right to buy) · Derivative | 2,609 | $0.00 Strike: $11.63 | $0.00 |
DisclosureSEC source: 0001637761-18-000078 · wf-form4_152694392428014.xml · derivative · entry 3 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,609 shares Expires 2018-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is immediately exercisable. Read SEC document |
| May 18, 2018 Filed May 21, 2018 23:06 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | SaleCommon Stock | 2,609 | $11.96 | $31,203.64 |
DisclosureSEC source: 0001637761-18-000078 · wf-form4_152694392428014.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,893 F1 · price: The price reported is a weighted average. These shares were sold in multiple transactions at prices ranging from not less than $11.85 to not more than $12.06. The reporting person undertakes to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| May 18, 2018 Filed May 21, 2018 23:06 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionCommon Stock | 2,609 | $11.63 | $30,342.67 |
DisclosureSEC source: 0001637761-18-000078 · wf-form4_152694392428014.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2018 Filed May 21, 2018 20:45 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 2,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-031901 · doc4.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,616 Read SEC document |
| May 17, 2018 Filed May 21, 2018 20:45 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 586 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-031901 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,651 Read SEC document |
| March 14, 2018 Filed Mar 15, 2018 17:26 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 171 | $9.97 | $1,704.87 |
DisclosureSEC source: 0001637761-18-000057 · wf-form4_152113479628398.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,893 F1 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on March 14, 2018. No shares were sold in connection with this transaction. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 21:12 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 15,658 | $0.00 Strike: $18.06 | $0.00 |
DisclosureSEC source: 0001209191-18-013864 · doc4.xml · derivative · entry 5 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,658 shares Expires 2018-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F3 · derivative.exercise_date: 25% of the stock options vest every quarter from the grant date of 5/19/2010. F4 · balance_after: This option was previously reported as covering 7,500 shares at an exercise price of $41.75 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 7,829 shares of common stock at an exercise price of $36.12 per share. F5 · balance_after: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 21:12 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | SaleCommon Stock | 15,658 | $55.00 | $861,255.76 |
DisclosureSEC source: 0001209191-18-013864 · doc4.xml · nonDerivative · entry 4 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,065 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $55 to $55.02. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 21:12 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Exercise / conversionCommon Stock | 15,658 | $18.06 | $282,783.48 |
DisclosureSEC source: 0001209191-18-013864 · doc4.xml · nonDerivative · entry 3 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,723 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 21:12 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 9 | $54.07 | $486.63 |
DisclosureSEC source: 0001209191-18-013864 · doc4.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,065 Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 21:12 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 40 | $54.07 | $2,162.80 |
DisclosureSEC source: 0001209191-18-013864 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,074 Read SEC document |
| December 14, 2017 Filed Dec 14, 2017 23:22 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 171 | $10.01 | $1,711.71 |
DisclosureSEC source: 0001637761-17-000171 · wf-form4_151329373960717.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,064 F1 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on December 14, 2017. No shares were sold in connection with this transaction. Read SEC document |
| November 23, 2017 Filed Nov 27, 2017 21:47 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 9 | $48.01 | $432.05 |
DisclosureSEC source: 0001209191-17-062593 · doc4.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,114 Read SEC document |
| November 23, 2017 Filed Nov 27, 2017 21:47 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 40 | $47.58 | $1,903.20 |
DisclosureSEC source: 0001209191-17-062593 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,123 Read SEC document |
| September 14, 2017 Filed Sep 15, 2017 14:31 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 171 | $10.39 | $1,776.69 |
DisclosureSEC source: 0001637761-17-000154 · wf-form4_150548589382194.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,235 F1 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on September 14, 2017. No shares were sold in connection with this transaction. Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 22:15 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 9 | $50.14 | $451.26 |
DisclosureSEC source: 0001209191-17-050203 · doc4.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,163 Read SEC document |
| August 23, 2017 Filed Aug 24, 2017 22:15 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 40 | $50.14 | $2,005.60 |
DisclosureSEC source: 0001209191-17-050203 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,172 Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 19:25 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantCommon Stock | 15,121 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-17-000122 · wf-form4_149755471811704.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,406 F1 · shares: The restricted stock award vests in four equal installments on each of September 14, 2017, December 14, 2017, March 14, 2018 and June 14, 2018, subject to the Reporting Person's continued service on the board of directors of SeaSpine Holdings Corporation ("SeaSpine") through each vesting date. F2 · balance_after: On July 1, 2015, Integra LifeSciences Holdings Corporation ("Integra") distributed 100% of the shares of common stock of SeaSpine that it owned to Integra stockholders of record as of the close of business on June 19, 2015. The distribution was made to the stockholders of Integra on a pro rata basis by means of a share dividend. Integra distributed to its stockholders one share of SeaSpine common stock for every three shares of Integra common stock held by stockholders of Integra as of the close of business on June 19, 2015. The distribution of SeaSpine shares was exempt from Section 16 of the Exchange Act by Rule 16a-9. Includes 3,727 shares of SeaSpine issued to the Reporting Person pursuant to the distribution in respect of shares of Integra held by him prior to the distribution. Read SEC document |
| June 07, 2017 Filed Jun 8, 2017 18:02 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 113 | $10.00 | $1,130.00 |
DisclosureSEC source: 0001637761-17-000112 · wf-form4_149694492723747.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,285 F1 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on June 7, 2017. No shares were sold in connection with this transaction. Read SEC document |
| May 24, 2017 Filed May 25, 2017 20:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 53 | $48.77 | $2,584.81 |
DisclosureSEC source: 0001209191-17-035362 · doc4.xml · nonDerivative · entry 4 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,212 Read SEC document |
| May 24, 2017 Filed May 25, 2017 20:25 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 12 | $48.77 | $585.24 |
DisclosureSEC source: 0001209191-17-035362 · doc4.xml · nonDerivative · entry 3 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,265 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.